Detalles de la búsqueda
1.
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
Cancer
; 2024 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38896056
2.
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry.
Haematologica
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634126
3.
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells.
Haematologica
; 108(2): 568-580, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36722406
4.
Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes.
Blood
; 133(3): 224-236, 2019 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30361261
5.
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Haematologica
; 106(12): 3079-3089, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179471
6.
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
Ann Hematol
; 100(5): 1181-1194, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740113
7.
Noninvasive prenatal diagnosis by cell-free DNA screening for fetomaternal HPA-1a platelet incompatibility.
Transfusion
; 58(10): 2272-2279, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30222855
8.
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.
Ann Hematol
; 97(11): 2217-2224, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019128
9.
Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications.
Int J Mol Sci
; 19(9)2018 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30205552
10.
Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches.
Biol Blood Marrow Transplant
; 23(12): 2042-2047, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28827064
11.
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.
Biol Blood Marrow Transplant
; 22(10): 1808-1815, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27470290
12.
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
Ann Hematol
; 100(7): 1917-1918, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33978823
13.
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 21(2): 266-74, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25445023
14.
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study.
Haematologica
; 100(10): 1294-300, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26160880
15.
Evaluation of a method for murine monocyte isolation by bone marrow depletion.
Anal Biochem
; 480: 42-8, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25892220
16.
Role of 18F-FDG-PET/CT in the management of marginal zone B cell lymphoma.
Hematol Oncol
; 33(4): 151-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25407794
17.
Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure.
Transfusion
; 55(4): 875-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25354577
18.
Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma.
Eur J Haematol
; 94(1): 23-30, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24520874
19.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther
; 30(2): 210.e1-210.e14, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043802
20.
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
Br J Haematol
; 162(4): 474-82, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23772672